Order Article Reprints

Havunen R, Kalliokoski R, Siurala M, Sorsa S, Santos JM, Cervera-Carrascon V, Anttila M, Hemminki A. Cytokine-Coding Oncolytic Adenovirus TILT-123 Is Safe, Selective, and Effective as a Single Agent and in Combination with Immune Checkpoint Inhibitor Anti-PD-1. Cells. 2021; 10(2):246. https://doi.org/10.3390/cells10020246

Havunen, Riikka, Riikka Kalliokoski, Mikko Siurala, Suvi Sorsa, João M. Santos, Victor Cervera-Carrascon, Marjukka Anttila, and Akseli Hemminki. 2021. "Cytokine-Coding Oncolytic Adenovirus TILT-123 Is Safe, Selective, and Effective as a Single Agent and in Combination with Immune Checkpoint Inhibitor Anti-PD-1" Cells 10, no. 2: 246. https://doi.org/10.3390/cells10020246

Havunen, R., Kalliokoski, R., Siurala, M., Sorsa, S., Santos, J. M., Cervera-Carrascon, V., Anttila, M., & Hemminki, A. (2021). Cytokine-Coding Oncolytic Adenovirus TILT-123 Is Safe, Selective, and Effective as a Single Agent and in Combination with Immune Checkpoint Inhibitor Anti-PD-1. Cells, 10(2), 246. https://doi.org/10.3390/cells10020246